Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 1/20 | 0.42 |
| ▸ | MAPT | P10636 | 1/20 | 0.42 |
| ▸ | ACHE | P22303 | 4/20 | 0.41 |
| ▸ | MAOA | P21397 | 4/20 | 0.40 |
| ▸ | TSHR | P16473 | 1/20 | 0.40 |
| ▸ | ATM | Q13315 | 1/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.38 |
| ▸ | GLA | P06280 | 2/20 | 0.38 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.37 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.37 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.37 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.37 |
| ▸ | CA1 | P00915 | 1/20 | 0.36 |
| ▸ | CA2 | P00918 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1011095 | 0.70 | PNMT (0.51) | CYP3A4MAPTACHEMAOATSHR | |
| Hydrochloric Acid SCHEMBL5708777 | 0.69 | PNMT (0.50) | CYP3A4MAPTACHEMAOATSHR | |
| SCHEMBL27753663 | 0.68 | ACHE (0.39) | CYP3A4MAPTACHEMAOATSHR | |
| SCHEMBL16930306 | 0.68 | CYP3A4 (0.42) | CYP3A4MAPTACHEMAOATSHR | |
| SCHEMBL12891538 | 0.68 | CYP3A4 (0.56) | CYP3A4MAPTACHEMAOATSHR | |
| SCHEMBL19284135 | 0.67 | CHEK1 (0.44) | CYP3A4MAPTACHECYP2C9MAPK1 | |
| SCHEMBL6948170 | 0.67 | MAOA (0.47) | CYP3A4MAPTMAOATSHRALDH1A1 | |
| SCHEMBL5458998 | 0.67 | CYP3A4 (0.41) | CYP3A4MAPTACHEMAOATSHR | |
| SCHEMBL3966470 | 0.66 | CYP3A4 (0.54) | CYP3A4MAPTACHEMAOAATM | |
| SCHEMBL27337452 | 0.64 | CYP3A4 (0.42) | CYP3A4MAPTACHEMAOAATM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20070265231-A1 | Hydrazide Compounds for Combating Animal Pests | BASF AKTIENGESELLSCHAFT (DE) | 2007-11-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070265231-A1 | Hydrazide Compounds for Combating Animal Pests | HRH4, CBR3, HRH2 | CYP3A4 990/4885MAPT 4808/4885ACHE 378/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.